Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer Kaiqi ZhangYuan XuKai Yin Research Open access 27 March 2024 Article: 75
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China Huan YanLianxi SongLiang Zeng Research Open access 07 March 2024 Article: 74
Oct4 activates IL-17A to orchestrate M2 macrophage polarization and cervical cancer metastasis Zhuoqiong BianXiaoling WuYidong Wang Research Open access 02 March 2024 Article: 73
A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer Gerald S. FalchookJames ReevesEmerson Lim Research Open access 02 March 2024 Article: 72
Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion Jianguo ZhangYangyi LiConghua Xie Research Open access 02 March 2024 Article: 71
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma Tanguy Y. SeiwertSophie WildsmithAmanda Psyrri Research Open access 02 March 2024 Article: 70
Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data Wenjun LiuXitu LuoHao Liu Research Open access 02 March 2024 Article: 69
Size selection of intrahepatic lesions for cryoablation contributes to abscopal effect and long-term survival in patients with liver metastatic melanoma receiving PD-1 blockade therapy Lujun ShenHongtong TanWeijun Fan Research Open access 02 March 2024 Article: 68
Neutrophils seeking new neighbors: radiotherapy affects the cellular framework and the spatial organization in a murine breast cancer model C. M. ReichardtM. Muñoz-BecerraL. E. Muñoz Research Open access 02 March 2024 Article: 67
Integrating molecular subtype and CD8+ T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancer Bingyu LiKaifeng JinWeijuan Zhang Research Open access 02 March 2024 Article: 66
Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity Jiawei YueHui GuoYumin Wu Research Open access 02 March 2024 Article: 65
Clinical immunotherapy in pancreatic cancer Xiaorong YeYue YuHongdi Ma Review Open access 02 March 2024 Article: 64
Riboflavin-LSD1 axis participates in the in vivo tumor-associated macrophage morphology in human colorectal liver metastases Cristiana SoldaniGiulia De SimoneLaura Brunelli Research Open access 02 March 2024 Article: 63
Mechanism exploration of Zoledronic acid combined with PD-1 in the treatment of hepatocellular carcinoma Xinru FanZijun YanHui Wang Research Open access 02 March 2024 Article: 62
Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma Zhengjie DaiXuan LinChen Liu Research Open access 02 March 2024 Article: 61
